Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts
NCT06812065 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2025-02-06
Summary
Hyperthermia treatment (hyperthermia) refers to treating diseases with temperature (39-45 ° C) beyond normal body temperature,. It has been reported that local warming at 44 ° C is able to effectively mobilize the body's immunity and clear HPV infected lesions, such as condyloma acuminatum and verruca vulgaris, etc.
Hydrogen peroxide (H2O2) is a commonly used disinfectant for skin debridement. It has been reported that high concentration of H2O2 (45% H2O2) is effective in the treatment of warts vulgaris, however, high concentration of H2O2 will cause more local pain, itching and burning sensation. 3% hydrogen peroxide is commonly used as skin debridement disinfectant.
The purpose of the study is to evaluate the efficacy and safety of 44℃ hyperthermia combined with 3% hydrogen peroxide in treating verruca virus.
Conditions
- Warts
Interventions
- DRUG
-
Hydrogen Peroxide 3 % Topical Solution
Dressing: Like the Local Hyperthermia Group, use a cotton ball soaked in 3% hydrogen peroxide. Irradiation: For seven sessions in three weeks, use simulated infrared light (without heat) with the same frequency as the Local Hyperthermia Group. Local Hyperthermia treats the target warts(largest and most severe warts), while medication addresses all warts.
- DEVICE
-
Local Hyperthermia at 44℃
(Patent No: ZL 200820231952.4, Model: YY-WRY-V01, Liaoning Yanyang Medical Instrument Co., Ltd., China) An infrared hyperthermia device was used to apply local hyperthermia at 44°C to the largest wart. The device includes a heating source, an infrared temperature monitor, an adjusting arm, a control circuit for temperature stabilization, and a display. It uses a tungsten-halogen lamp (wavelength: 760-2300 nm, peak at 1200 nm) to maintain the temperature of a 0.5\*0.5 cm skin area within ±0.1°C using a non-contact infrared feedback system.Hyperthermia: Conduct 44-degree Celsius, 30-minute sessions. Do it daily for the first 3 days, then 2 sessions every 7 days for 3 weeks, for a total of 7 sessions. Dressing: Apply a cotton ball soaked in 0.9% saline to the warts, wrap it with plastic film for 1 hour, and do this once a day for 6 weeks. Local Hyperthermia treats the target warts(largest and most severe warts), while medication addresses all warts.
Sponsors & Collaborators
-
First Hospital of China Medical University
lead OTHER
Principal Investigators
-
Xinghua Gao · First Hospital of China Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-07
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts
NCT04288817 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts
NCT05712811 ·Status: COMPLETED ·Phase: NA
-
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
NCT05617950 ·Status: UNKNOWN ·Phase: NA
-
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts
NCT05616078 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts
NCT06691542 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Topical Methotrexate Gel 1% Coupled With Microneedling in Treatment of Warts
NCT05300009 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Laser Versus Cryotherapy in the Treatment of Warts
NCT01808443 ·Status: COMPLETED ·Phase: NA
-
Chlorhexidine and Garlic Extract as Potential Topical Virucidal Therapeutic Agents of Non-Genital Warts
NCT06077032 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts
NCT02015260 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Plantar Warts
NCT05198180 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts
NCT05588999 ·Status: COMPLETED ·Phase: PHASE1
-
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts
NCT04814446 ·Status: RECRUITING ·Phase: PHASE3
-
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
NCT03981822 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts
NCT06809777 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study With a Topical Gel to Treat Common Warts in Adults
NCT00117923 ·Status: COMPLETED ·Phase: PHASE2
-
Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)
NCT05877313 ·Status: COMPLETED ·Phase: PHASE2
-
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts
NCT03948321 ·Status: UNKNOWN ·Phase: NA
-
A Study of A-101 Solution in Subjects With Common Warts.
NCT02669862 ·Status: COMPLETED ·Phase: PHASE2
-
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
NCT00114920 ·Status: COMPLETED ·Phase: PHASE2
-
Topical 2% Povidone-Iodine Gel in Verruca Vulgaris
NCT04253912 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients
NCT03153566 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.
NCT06973473 ·Status: NOT_YET_RECRUITING
-
Cantharone for the Treatment of Perenial Warts
NCT03625960 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts.
NCT06718192 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts
NCT02106260 ·Status: COMPLETED ·Phase: PHASE1/PHASE2